Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Registration for this session is additional to the congress registration fee and is €268 on site, €244 standard
Aims : To highlight the most recent advances in diagnostics and therapy which every chest physician should be aware of when piloting and tailoring personalised care for lung cancer patients in a multi-professional setting; to provide an overview of the rapidly evolving lung cancer care with the goal of chronifying a so far almost devastating disease.
Target audience :
Allied health professional, Clinician, Emergency medicine doctor, Fellow, General practitioner, Immunologist, Intensivist/critical care physician, Junior member, Lung function technician, Nurse, Oncologist, Pathologist, Patient, Pulmonologist, Radiologist, Researcher, Resident, Respiratory physician, Respiratory therapist, Scientist, Student, Thoracic endoscopist, Thoracic surgeon, Trainee, Pharmaceutical industry representative